drugset

drugset / Trial / NCT00583154

A Pilot Efficacy Evaluation of BLI-801 as a Laxative in Constipated Adults

NCT00583154 ↗

Phase 2 Completed 60 enrolled Braintree Laboratories

RandomizedParallel-groupOpen-labelTreatment

Summary

To compare the safety and efficacy of BLI-801 administered at 4 dose levels in constipated adults.

Timeline

Start: 2007-10
Primary completion: 2008-01
Completion: 2008-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	BLI801	Unknown	—	—

Indications